Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · March 18, 2021

Antiplatelet Therapy and Survival in Moyamoya Disease

Journal of the American Heart Association

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Heart Association
Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study
J Am Heart Assoc 2021 Feb 22;[EPub Ahead of Print], WK Seo, JY Kim, EH Choi, YS Kim, JW Chung, JL Saver, OY Bang, GM Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading